United States · FDA National Drug Code directory
NYSTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69315-307_520822eb-a9f1-4017-9a73-1979ee53f4e9
- Product NDC
- 69315-307
- Form
- OINTMENT
- Composition / generic term
- NYSTATIN
- Labeler
- Leading Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190819
- Source listing expiry
- 20261231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (69315-307-15) / 15 g in 1 TUBE · 69315-307-15
- 1 TUBE in 1 CARTON (69315-307-30) / 30 g in 1 TUBE · 69315-307-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →